Skip to main content

Advertisement

Log in

Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma

  • Published:
Journal of Biomedical Science

Abstract

The study sought to explore if androgen receptor gene (AR) polymorphisms are associated with the risk of urothelial carcinoma (UC) which is male-predominant. AR CAG and GGN repeat lengths were analyzed in 277 UC cases and 280 age and sex-matched controls by direct sequencing of leukocyte DNA. Smoking habits were obtained using a structured questionnaire interview. Relative risks were compared between groups categorized by all possible cutoffs of AR CAG and GGN repeat lengths. Men and women who had 23 and 44 (cumulative) CAG repeats had a significantly greater risk of UC, respectively (OR 2.09, 95% CI: 1.05–4.17, p = 0.036 and OR 4.95, 95% CI: 1.56–15.73, p = 0.007). Amongst males who were medium-dose cigarette smokers, those who had 23 CAG and shorter GGN (<22) repeats, had an elevated risk than those with longer CAG and GGN (OR 4.32 and 4.57, p = 0.034 and 0.042, respectively). However, neither CAG nor GGN affected the UC risk in non-smokers or heavy smokers (≥25 packs per day-years). AR CAG polymorphism may affect the risk of UC in both genders. In addition, AR polymorphisms may influence carcinogenic effect of medium-dose of cigarette smoking in men.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Hsing A.W., Gao Y.T., Wu G., Wang X., Deng J., Chen Y.L., Sesterhenn I.A., Mostofi F.K., Benichou J., Chang C. Polymorphic CAG and GGN repeat lengths in the androgen receptor gene and prostate cancer risk: a population-based case–control study in China. Cancer Res. 60: 5111–5116, 2000

    PubMed  CAS  Google Scholar 

  2. Chamberlain N.L., Driver E.D., Miesfeld R.L., The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res. 22: 3181–3186, 1994

    Article  PubMed  CAS  Google Scholar 

  3. Ding D., Xu L., Menon M., Reddy G.P., Barrack E.R., Effect of GGC (glycine) repeat length polymorphism in the human androgen receptor on androgen action. Prostate 62: 133, 2005

    Article  PubMed  CAS  Google Scholar 

  4. Montgomery J.S., Price D.K., Figg W.D., The androgen receptor gene and its influence on the development and progression of prostate cancer. J. Pathol. 195: 138–146, 2001

    Article  PubMed  CAS  Google Scholar 

  5. Yu H., Bharaj B., Vassilikos E.J., Giai M., Diamandis E.P., Shorter CAG repeat length in the androgen receptor gene is associated with more aggressive forms of breast cancer Breast Cancer Res. Treat. 59: 153–161, 2000

    Article  PubMed  CAS  Google Scholar 

  6. Li A.J., Baldwin R.L., Karlan B.Y., Short androgen receptor allele length is a poor prognostic factor in epithelial ovarian carcinoma. Clin. Cancer Res. 9: 3667–3673, 2003

    PubMed  CAS  Google Scholar 

  7. Edwards S.M., Badzioch M.D., Minter R., Hamoudi R., Collins N., Ardern-Jones A., Dowe A., Osborne S., Kelly J., Shearer R., Easton D.F., Saunders G.F., Dearnaley D.P., Eeles R.A., Androgen receptor polymorphisms: association with prostate cancer risk, relapse and overall survival Int. J. Cancer 84: 458–465, 1999

    Article  PubMed  CAS  Google Scholar 

  8. Jemal A., Murray T., Samuels A., Ghafoor A., Ward E., Thun M.J., Cancer statistics, 2003 CA Cancer J. Clin. 53: 5–26, 2003

    Article  PubMed  Google Scholar 

  9. Boorman G.A., Animal model of human disease: carcinoma of the ureter and urinary bladder Am. J. Pathol. 88: 251–254, 1977

    PubMed  CAS  Google Scholar 

  10. Cheng L., MacLennan G.T., Pan C.X., Jones T.D., Moore C.R., Zhang S., Gu J., Patel N.B., Kao C., Gardner T.A., Allelic loss of the active X chromosome during bladder carcinogenesis. Arch. Pathol. Lab. Med. 128: 187–190, 2004

    PubMed  CAS  Google Scholar 

  11. Boorjian S., Ugras S., Mongan N.P., Gudas L.J., You X., Tickoo S.K., Scherr D.S., Androgen receptor expression is inversely correlated with pathologic tumor stage in bladder cancer. Urology 64: 383–388, 2004

    Article  PubMed  Google Scholar 

  12. Yeh S.H., Chang C.F., Shau W.Y., Chen Y.W., Hsu H.C., Lee P.H., Chen D.S., Chen P.J., Dominance of functional androgen receptor allele with longer CAG repeat in hepatitis B virus-related female hepatocarcinogenesis. Cancer Res. 62: 4346–4351, 2002

    PubMed  CAS  Google Scholar 

  13. Burch J.D., Rohan T.E., Howe G.R., Risch H.A., Hill G.B., Steele R., Miller A.B., Risk of bladder cancer by source and type of tobacco exposure: a case–control study. Int. J. Cancer 44: 622–628, 1989

    Article  PubMed  CAS  Google Scholar 

  14. Chiou H.Y., Hsueh Y.M., Liaw K.F., Horng S.F., Chiang M.H., Pu Y.S., Lin J.S., Huang C.H., Chen C.J., Incidence of internal cancers and ingested inorganic arsenic: a seven-year follow-up study in Taiwan. Cancer Res. 55: 1296–1300, 1995

    PubMed  CAS  Google Scholar 

  15. Suter N.M., Malone K.E., Daling J.R., Doody D.R., Ostrander E.A., Androgen receptor (CAG)n and (GGC)n polymorphisms and breast cancer risk in a population-based case–control study of young women. Cancer Epidemiol. Biomarkers Prev. 12: 127–135, 2003

    PubMed  CAS  Google Scholar 

  16. Liede A., Zhang W., Leon Matsuda M.L., Tan A., Narod S.A., Androgen receptor gene polymorphism and breast cancer susceptibility in The Philippines. Cancer Epidemiol. Biomarkers Prev. 12: 848–852, 2003

    PubMed  CAS  Google Scholar 

  17. Roberts R.O., Bergstralh E.J., Cunningham J.M., Hebbring S.J., Thibodeau S.N., Lieber M.M., Jacobsen S.J., Androgen receptor gene polymorphisms and increased risk of urologic measures of benign prostatic hyperplasia. Am. J. Epidemiol. 159: 269–276, 2004

    Article  PubMed  Google Scholar 

  18. Gacy A.M., Goellner G., Juranic N., Macura S., McMurray C.T., Trinucleotide repeats that expand in human disease form hairpin structures in vitro. Cell 81: 533–540, 1995

    Article  PubMed  CAS  Google Scholar 

  19. Yeap B.B., Wilce J.A., Leedman P.J., The androgen receptor mRNA. Bioessays 26: 672–682, 2004

    Article  PubMed  CAS  Google Scholar 

  20. Gottlieb B., Beitel L.K., Wu J.H., Trifiro M., The androgen receptor gene mutations database (ARDB): 2004 update. Hum. Mutat. 23: 527–533 2004

    Article  PubMed  CAS  Google Scholar 

  21. Choudhry M.A., McEwan I.J., In vitro regulation of reporter gene transcription by the androgen receptor AF1 domain. Biochem. Soc. Trans. 32:1103–1106 2004

    Article  PubMed  CAS  Google Scholar 

  22. Reid J., Betney R., Watt K., McEwan I.J., The androgen receptor transactivation domain: the interplay between protein conformation and protein–protein interactions. Biochem. Soc. Trans. 31: 1042–1046 2003

    PubMed  CAS  Google Scholar 

  23. Heinlein C.A., Chang C., Androgen receptor (AR) coregulators: an overview. Endocr. Rev. 23: 175–200 2002

    Article  PubMed  CAS  Google Scholar 

  24. Yu M.C., Skipper P.L., Tannenbaum S.R., Chan K.K., Ross R.K., Arylamine exposures and bladder cancer risk. Mutat. Res. 506–507: 21–28 2002

    PubMed  Google Scholar 

  25. Garcia-Closas M., Malats N., Silverman D., Dosemeci M., Kogevinas M., Hein D.W., Tardon A., Serra C., Carrato A., Garcia-Closas R., Lloreta J., Castano-Vinyals G., Yeager M., Welch R., Chanock S., Chatterjee N., Wacholder S., Samanic C., Tora M., Fernandez F., Real F.X., Rothman N., NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 366: 649–659 2005

    Article  PubMed  CAS  Google Scholar 

  26. Matullo G., Guarrera S., Sacerdote C., Polidoro S., Davico L., Gamberini S., Karagas M., Casetta G., Rolle L., Piazza A., Vineis P., Polymorphisms/haplotypes in DNA repair genes and smoking: a bladder cancer case–control study. Cancer Epidemiol. Biomarkers Prev. 14: 2569–2578 2005

    Article  PubMed  CAS  Google Scholar 

  27. Berman D.M., Wang Y., Liu Z., Dong Q., Burke L.A., Liotta L.A., Fisher R., Wu X., A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res. 64: 6820–6826 2004

    Article  PubMed  CAS  Google Scholar 

  28. Hsieh F.I., Pu Y.S., Chern H.D., Hsu L.I., Chiou H.Y., Chen C.J., Genetic polymorphisms of N-acetyltransferase 1 and 2 and risk of cigarette smoking-related bladder cancer. Br. J. Cancer 81: 537–541 1999

    Article  PubMed  CAS  Google Scholar 

  29. Yu M.W., Cheng S.W., Lin M.W., Yang S.Y., Liaw Y.F., Chang H.C., Hsiao T.J., Lin S.M., Lee S.D., Chen P.J., Liu C.J., Chen C.J., Androgen-receptor gene CAG repeats, plasma testosterone levels, and risk of hepatitis B-related hepatocellular carcinoma. J. Natl. Cancer Inst. 92: 2023–2028 2000

    Article  PubMed  CAS  Google Scholar 

  30. Visvanathan K., Helzlsouer K.J., Boorman D.W., Strickland P.T., Hoffman S.C., Comstock G.W., O’Brien T.G., Guo Y., Association among an ornithine decarboxylase polymorphism, androgen receptor gene (CAG) repeat length and prostate cancer risk. J. Urol. 171: 652–655 2004

    Article  PubMed  Google Scholar 

  31. Nakanishi H., Takeuchi S., Kato K., Shimizu S., Kobayashi K., Tatematsu M., Shirai T., Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2′-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats. Jpn. J. Cancer Res. 87: 1218–1226 1996

    PubMed  CAS  Google Scholar 

  32. Svartberg J., Midtby M., Bonaa K.H., Sundsfjord J., Joakimsen R.M., Jorde R., The associations of age, lifestyle factors and chronic disease with testosterone in men: the Tromso Study. Eur. J. Endocrinol. 149: 145–152 2003

    Article  PubMed  CAS  Google Scholar 

  33. Trummer H., Habermann H., Haas J., Pummer K., The impact of cigarette smoking on human semen parameters and hormones. Hum. Reprod. 17: 1554–1559 2002

    Article  PubMed  Google Scholar 

  34. Marsh J.D., Lehmann M.H., Ritchie R.H., Gwathmey J.K., Green G.E., Schiebinger R.J., Androgen receptors mediate hypertrophy in cardiac myocytes. Circulation 98: 256–261 1998

    PubMed  CAS  Google Scholar 

  35. Racchi O., Mangerini R., Rapezzi D., Rolfo M., Gaetani G.F., Ferraris A.M., X chromosome inactivation patterns in normal females. Blood Cells Mol. Dis. 24: 439–447 1998

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study was supported by grants (91GMP012-3 and 91GMP012-4) from the National Science Council, Executive Yuan, Republic of China.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yeong-Shiau Pu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Liu, CH., Huang, Jd., Huang, SW. et al. Androgen receptor gene polymorphism may affect the risk of urothelial carcinoma. J Biomed Sci 15, 261–269 (2008). https://doi.org/10.1007/s11373-007-9215-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11373-007-9215-x

Keywords

Navigation